SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's has become a focal point for retail traders who are attempting to force a short squeeze, driven by high trading volume and active discussions on social media platforms about saving the brand. Community members are debating the company's valuation and potential upside, with many expressing bullish sentiment based on the stock's dividend and the hope for a dramatic price surge.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing a significant sell-off as investors grapple with its high leverage to Bitcoin, leading to intense community debate over whether current price levels represent a generational buying opportunity or the beginning of a structural collapse. The stock is facing heavy downward pressure amid broader concerns about crypto market volatility and questions regarding the sustainability of the company's aggressive acquisition strategy.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is facing intense selling pressure as community sentiment fractures between long-term holders advocating for strategic accumulation and vocal bears declaring the asset a failed experiment. Investors are actively debating the impact of institutional outflows and the potential for a deeper correction while monitoring technical support levels that many fear could trigger a broader market decline.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as market participants brace for earnings that are widely viewed as a make-or-break catalyst for the broader semiconductor and AI sector. The community is deeply divided, with discussions centered on whether recent volatility reflects a healthy shakeout before a post-earnings rally or a structural correction due to sky-high expectations and shifting demand cycles.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is facing heavy selling pressure as investors grapple with shifting interest rate expectations and a strengthening U.S. dollar, leading many in the community to weigh in on whether current levels represent a capitulation bottom or the start of a deeper cyclical correction. While some are doubling down on long-term physical accumulation citing supply deficits and industrial demand, others are expressing frustration over the lack of momentum and are actively debating the viability of holding silver against traditional growth equities.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is facing intense retail scrutiny and negative sentiment as investors express frustration over ongoing share dilution and a widening disconnect between the stock's performance and its Ethereum holdings. Community discourse is currently dominated by calls for management accountability and widespread debate regarding whether the stock's recent volatility represents a capitulation bottom or a terminal decline.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae is trending as retail investors and institutional players debate the timing of a potential IPO and the end of government conservatorship, fueled by recent commentary suggesting a significant valuation for the firm. While some participants are aggressively accumulating shares in anticipation of a massive catalysts, others express deep frustration and skepticism regarding the timeline and the influence of political rhetoric on price action.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as investors react to the company's initiation of a Phase 1 clinical trial for VK3019, a novel obesity drug, while social media chatter intensifies around potential M&A activity and the stock's significant short interest. Community sentiment is driven by speculation regarding near-term partnerships or a buyout, with many long-term holders pointing to the upcoming Q3 maintenance study data as a critical catalyst to unlock value against competitors.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is facing heightened scrutiny and volatility following the announcement that its CFO will step down in August, sparking investor concerns over long-term financial stability and strategic direction. While the community remains divided between those capitalizing on the high dividend yield and those aggressively calling for a leadership change due to perceived stagnation in the oncology and weight-loss pipelines, market participants are closely watching the stock's support levels as it struggles to regain sustained upward momentum.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors digest the company's strategic move to acquire infrastructure startup Modular, a deal seen as a play to bridge the software gap and challenge Nvidia's software dominance in the AI data center market. The community remains divided, with some investors focusing on long-term AI potential and upcoming catalyst events, while others express frustration over recent stock volatility and the perceived lack of momentum despite these aggressive growth initiatives.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anika Therapeutics (NASDAQ:ANIK) Director John Henneman III Buys 5,000 Shares

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) Director John Henneman III acquired 5,000 shares of the stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $14.66 per share, with a total value of $73,300.00. Following the transaction, the director...

Anika Therapeutics (NASDAQ:ANIK) CEO Stephen Griffin Purchases 12,200 Shares

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin purchased 12,200 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were bought...

Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin bought 12,200 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average...

Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.17 EPS

Anika Therapeutics (NASDAQ:ANIK - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.24) EPS for the quarter, missing analysts' consensus...

Anika Therapeutics Q1 Earnings Call Highlights

Anika Therapeutics (NASDAQ:ANIK) reported first-quarter 2026 results highlighting continued momentum in its commercial channel, progress in its hyaluronic acid (HA)-based product pipeline, and early...

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell...

Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200 Day Moving Average - Should You Sell?

Anika Therapeutics (NASDAQ:ANIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell...

Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200 Day Moving Average   - What's Next?

Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200 Day Moving Average - What's Next...

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average   - Time to Sell?

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Here's Why...

Anika Therapeutics (NASDAQ:ANIK) Shares Pass Above 200-Day Moving Average - What's Next?

Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving Average - Here's What Happened...

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Anika Therapeutics Inc.

Retail Investors Remain Cautious After Anika’s Q3 Earnings Misses Estimates

Equity

Neutral Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Current Price	$14.79
Prev Close	$14.59
Open	$14.70
Dividend Yield	0.00%
50-Day Moving Average	$14.80
Beta	0.89
Avg. Volume	90,495.26
PE Ratio	-18.43

52-Week High	$16.24
52-Week Low	$7.87
Market Capitalization	$194.13M
EPS (Annual)	-$0.7588
Price to Book	1.46
Revenue Per Employee	$480,080.85

Feed

News

Sentiment

Earnings

Fundamentals

Info

ANIKAnika Therapeutics Inc.

Latest ANIK News